Inspire Medical Systems, Inc. (INSP) — 分析摘要
Inspire Medical Systems, Inc.(INSP)的市值为1.48十亿美元,最近一年的营收同比增长了+13.6%。净利润率为15.9%。当前市盈率为11.3倍。
核心要点
- 营收同比变化+13.6%
- 净利润率15.9%
- 市盈率11.3倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,INSP的营收增长为+13.6%,市盈率为11.3倍。
Inspire Medical Systems, Inc. (INSP)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
1,333
总部
GOLDEN VALLEY, MN
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。